Cantor Fitzgerald Predicts AARD FY2026 Earnings
Aardvark Therapeutics, Inc. (NASDAQ:AARD – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Aardvark Therapeutics in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer forecasts that the company will earn ($2.52) per share for the year. Cantor Fitzgerald has a “Overweight” rating […]
Aardvark Therapeutics, Inc. (NASDAQ:AARD – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Aardvark Therapeutics in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer forecasts that the company will earn ($2.52) per share for the year. Cantor Fitzgerald has a “Overweight” rating […]
